Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OSCR · against 166 other Healthcare companies of similar size
Ranked #14 of 167 · scores higher than 92% of peers
Bars: peers in each 10-point band of the valuation score15 peers with a valuation score of 90–100, including OSCR · Click a bar to see the companies
Mainly thanks to its free cash flow yield, EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | OSCR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 166 reported | 4.0% | 2.5% | 73% | 30% | |
| EBITDA yieldHigher is better · 166 reported | 34.2% | 4.7% | 100% | 50% | |
| Free cash flow yieldHigher is better · 101 reported | 43.8% | 2.3% | 100% | 20% | |
| Book yieldHigher is better · 165 reported | 20.5% | 18.8% | 54% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 2 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 3 | 10.4B USD | 96 | 64 | |
| 4 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 5 | 11.6B USD | 94 | 58 | |
| 11 | 45.1B HKD (≈$5.8B) | 91 | 53 | |
| 11 | 1.30T JPY (≈$8.8B) | 91 | 71 | |
| 11 | 884.9B JPY (≈$6.0B) | 91 | 61 | |
| 14 | 47.7B CNY (≈$6.7B) | 90 | 64 | |
| 14 | 10.0B USD | 90 | 64 | |
| 16 | 43.1B CNY (≈$6.0B) | 89 | 72 | |
| 16 | 66.0B BRL (≈$11.9B) | 89 | 55 | |
| 18 | 2.57T JPY (≈$17.5B) | 88 | 62 | |
| 19 | 1.03T JPY (≈$7.0B) | 87 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score